Respiratory viruses and their impact in healthcare

Current Opinion in Infectious Diseases

Volumn 27, Issue 4, 2014, Pages 342-347

  Rao, Suchitra ^a   Nyquist, Ann Christine ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Global Health and Health Disparities   (United States)

Author keywords

Healthcare associated infections; Infection control; Influenza; Nosocomial infections; Respiratory viruses

Indexed keywords

ADULT; CROSS INFECTION; HUMAN; INFECTION CONTROL; NEWBORN; RESPIRATORY TRACT INFECTIONS; VIROLOGY; VIRUS DISEASES;

ADULT; CROSS INFECTION; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 84905909111     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000079     Document Type: Review

References (58)

1. Coia JE, Ritchie L, Adisesh A, et al. Guidance on the use of respiratory and facial protection equipment. J Hosp Infect 2013; 85:170-182.
2. Bunyan D, Ritchie L, Jenkins D, Coia JE. Respiratory and facial protection: a critical review of recent literature. J Hosp Infect 2013; 85:165-169.
3. Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine patient care. J Infect Dis 2013; 207:1037-1046.
4. Makison Booth C, Clayton M, Crook B, Gawn JM. Effectiveness of surgical masks against influenza bioaerosols. J Hosp Infect 2013; 84:22-26.
5. Gralton J, Tovey ER, McLaws ML, Rawlinson WD. Respiratory virus RNA is detectable in airborne and droplet particles. J Med Virol 2013; 85:2151-2159.
6. Tran K, Cimon K, Severn M, et al. Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review. CADTH Technol Overv 2013; 3:e3201.
7. Thompson KA, Pappachan JV, Bennett AM, et al. Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic\-The risk of aerosol generation during medical procedures. PLoS One 2013; 8:e56278.
8. Hall CB. The spread of influenza and other respiratory viruses: complexities and conjectures. Clin Infect Dis 2007; 45:353-359.
9. Zerr DM, Milstone AM, Huskins WC, Bryant KA. The past, present, and future of healthcare-Associated infection prevention in pediatrics: viral respiratory infections. Infect Control Hosp Epidemiol 2010; 31 (Suppl 1):S22-S26.
10. Blachere FM, Lindsley WG, Pearce TA, et al. Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis 2009; 48:438-440.
11. Fabian P, McDevitt JJ, DeHaan WH, et al. Influenza virus in human exhaled breath: an observational study. PLoS One 2008; 3:e2691.
12. Milton DK, Fabian MP, Cowling BJ, et al. Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog 2013; 9:e1003205.
13. MacIntyre CR, Wang Q, Seale H, et al. A randomized clinical trial of three options for N95 respirators and medical masks in health workers. Am J Respir Crit Care Med 2013; 187:960-966.
14. Bessesen MT, Savor-Price C, Simberkoff M, et al. N95 respirators or surgical masks to protect healthcare workers against respiratory infections: are we there yet? Am J Respir Crit Care Med V 187 2013; 904-905.
15. Seto WH, Conly JM, Pessoa-Silva CL, et al. Infection prevention and control measures for acute respiratory infections in healthcare settings: an update. East Mediterr Health J 2013; 19 (Suppl 1):S39-S47.
16. Thomas Y, Boquete-Suter P, Koch D, et al. Survival of influenza virus on human fingers. Clin Microbiol Infect 2014; 20:O58-O64.
17. Sidler JA, Haberthur C, Dumoulin A, et al. A retrospective analysis of nosocomial viral gastrointestinal and respiratory tract infections. Pediatr Infect Dis J 2012; 31:1233-1238.
18. Turner RB, Fuls JL, Rodgers ND. Effectiveness of hand sanitizers with and without organic acids for removal of rhinovirus from hands. Antimicrob Agents Chemother 2010; 54:1363-1364.
19. Turner RB, Fuls JL, Rodgers ND, et al. A randomized trial of the efficacy of hand disinfection for prevention of rhinovirus infection. Clin Infect Dis 2012; 54:1422-1426.
20. Esbenshade JC, Edwards KM, Esbenshade AJ, et al. Respiratory virus shedding in a cohort of on-duty healthcare workers undergoing prospective surveillance. Infect Control Hosp Epidemiol 2013; 34:373-378.
21. Milstone AM, Perl TM, Valsamakis A. Epidemiology of respiratory viruses in children admitted to an infant/toddler unit. Am J Infect Control 2012; 40:462-464.
22. Ahmed F, Lindley MC, Allred N, et al. Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis 2014; 58:50-57.
23. Dolan GP, Harris RC, Clarkson M, et al. Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic review. Influenza Other Respir Viruses 2013; 7 (Suppl 2):93-96.
24. Antommaria AH. An ethical analysis of mandatory influenza vaccination of healthcare personnel: implementing fairly and balancing benefits and burdens. Am J Bioeth 2013; 13:30-37.
25. Fouchier RA, Rimmelzwaan GF, Kuiken T, Osterhaus AD. Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses. Curr Opin Infect Dis 2005; 18:141-146.
26. Xu M, Qin X, Astion ML, et al. Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. Am J Clin Pathol 2013; 139:118-123.
27. Vallieres E, Renaud C. Clinical and economical impact of multiplex respiratory virus assays. Diagn Microbiol Infect Dis 2013; 76:255-261.
28. Mills JM, Harper J, Broomfield D, Templeton KE. Rapid testing for respiratory syncytial virus in a paediatric emergency department: benefits for infection control and bed management. J Hosp Infect 2011; 77:248-251.
29. Posfay-Barbe KM, Zerr DM, Pittet D. Infection control in paediatrics. Lancet Infect Dis 2008; 8:19-31.
30. Gunson RN, Carman WF. During the summer 2009 outbreak of "swine flu" in Scotland what respiratory pathogens were diagnosed as H1N1/2009? BMC Infect Dis 2011; 11:192.
31. Letant SE, Ortiz JI, Bentley Tammero LF, et al. Multiplexed reverse transcriptase PCR assay for identification of viral respiratory pathogens at the point of care. J Clin Microbiol 2007; 45:3498-3505.
32. Rhedin S, Lindstrand A, Rotzen-Ostlund M, et al. Clinical utility of PCR for common viruses in acute respiratory illness. Pediatrics 2014; 133:e538-e545.
33. Ginocchio CC. Strengths and weaknesses of FDA-Approved/cleared diagnostic devices for the molecular detection of respiratory pathogens. Clin Infect Dis 2011; 52 (Suppl 4):S312-S325.
34. Henrickson KJ, Hall CB. Diagnostic assays for respiratory syncytial virus disease. Pediatr Infect Dis J 2007; 26 ( Suppl 11):S36-S40.
35. Civardi E, Tzialla C, Baldanti F, et al. Viral outbreaks in neonatal intensive care units: what we do not know. Am J Infect Control 2013; 41:854-856.
36. Bennett NJ, Tabarani CM, Bartholoma NM, et al. Unrecognized viral respiratory tract infections in premature infants during their birth hospitalization: a prospective surveillance study in two neonatal intensive care units. J Pediatr 2012; 161:814-818.
37. Hall CB, Kopelman AE, Douglas RG Jr, et al. Neonatal respiratory syncytial virus infection. N Engl J Med 1979; 300:393-396.
38. Hall CB, Douglas RG Jr, Geiman JM, Messner MK. Nosocomial respiratory syncytial virus infections. N Engl J Med 1975; 293:1343-1346.
39. Hall CB, Geiman JM, Douglas RG Jr, Meagher MP. Control of nosocomial respiratory syncytial viral infections. Pediatrics 1978; 62:728-732.
40. Gagliardi TB, Paula FE, Iwamoto MA, et al. Concurrent detection of other respiratory viruses in children shedding viable human respiratory syncytial virus. J Med Virol 2013; 85:1852-1859.
41. Weedon KM, Rupp AH, Heffron AC, et al. The impact of infection control upon hospital-Acquired influenza and respiratory syncytial virus. Scand J Infect Dis 2013; 45:297-303.
42. Yin J, Schweizer ML, Herwaldt LA, et al. Benefits of universal gloving on hospital-Acquired infections in acute care pediatric units. Pediatrics 2013; 131:e1515-e1520.
43. O'Connell K, Boo TW, Keady D, et al. Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction. J Hosp Infect 2011; 77:338-342.
44. Pavia AT. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis 2011; 52 (Suppl 4):S284-S289.
45. Singh AK, Jain B, Verma AK, et al. Hospital outbreak of human respiratory syncytial virus (HRSV) illness in immunocompromised hospitalized children during summer. Clin Respir J 2014. [Epub ahead of print]
46. Harvala H, Gaunt E, McIntyre C, et al. Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unit. J Infect 2012; 65:246-254.
47. Srinivasan A, Gu Z, Smith T, et al. Prospective detection of respiratory pathogens in symptomatic children with cancer. Pediatr Infect Dis J 2013; 32:e99-e104.
48. Lo MS, Lee GM, Gunawardane N, et al. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant 2013; 17:133-143.
49. Godbole G, Gant V. Respiratory tract infections in the immunocompromised. Curr Opin Pulm Med 2013; 19:244-250.
50. Abad C, Fearday A, Safdar N. Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect 2010; 76:97-102.
51. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with Contact Precautions: a review of the literature. Am J Infect Control 2009; 37:85-93.
52. Legoff J, Guerot E, Ndjoyi-Mbiguino A, et al. High prevalence of respiratory viral infections in patients hospitalized in an intensive care unit for acute respiratory infections as detected by nucleic acid-based assays. J Clin Microbiol 2005; 43:455-457.
53. van Asten L, van den Wijngaard C, van Pelt W, et al. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis 2012; 206:628-639.
54. Lee N, Lui GC, Wong KT, et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 2013; 57:1069-1077.
55. Fukuta Y, Muder RR. Infections in psychiatric facilities, with an emphasis on outbreaks. Infect Control Hosp Epidemiol 2013; 34:80-88.
56. Centers for Disease Control and Prevention. Outbreaks of human metapneumovirus in two skilled nursing facilities-West Virginia and Idaho, 2011-2012. MMWR Morb Mortal Wkly Rep 2013; 62:909-913.
57. Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013; 369:407-416.
58. Guery B, Poissy J, el Mansouf L, et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 2013; 381:2265-2272.